'Vitamin D and cognition in older adults': Updated international recommendations

Journal of Internal Medicine

Volumn 277, Issue 1, 2015, Pages 45-57

  Annweiler, C ^a,b   Dursun, E ^c   Feron F ^d   Gezen Ak, D ^c   Kalueff, A V ^e   Littlejohns, T ^f   Llewellyn, D J ^f   Millet, P ^d   Scott, T ^g   Tucker, K L ^h   Yilmazer, S ^c   Beauchet, O ^a  

^a ANGERS UNIVERSITY HOSPITAL   (France)

^b ROBARTS RESEARCH INSTITUTE   (Canada)

^c ISTANBUL UNIVERSITY   (Turkey)

^d Mediterranée University   (France)

^e ZENEREI Institute   (United States)

^f UNIVERSITY OF EXETER MEDICAL SCHOOL   (United Kingdom)

^g TUFTS UNIVERSITY   (United States)

^h UNIVERSITY OF MASSACHUSETTS LOWELL   (United States)

Author keywords

Alzheimer's disease; Brain; Cognition; Neuroendocrinology; Older adults; Vitamin D

Indexed keywords

CALCITRIOL; VITAMIN D;

BLOOD BRAIN BARRIER; CALCIUM HOMEOSTASIS; CEREBROSPINAL FLUID; COGNITION; COGNITIVE DEFECT; HIPPOCAMPUS; HUMAN; HYPOTHALAMUS; MATERNAL BEHAVIOR; NERVE CELL DIFFERENTIATION; NEUROPROTECTION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SUBCORTEX; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION; ADVISORY COMMITTEE; AGED; ALZHEIMER DISEASE; BLOOD; COGNITION DISORDERS; COMPLICATION; CONSENSUS; DEMENTIA; DIET SUPPLEMENTATION; FEMALE; FOLLOW UP; GERIATRIC ASSESSMENT; INTERNATIONAL COOPERATION; MALE; PATHOPHYSIOLOGY; PRACTICE GUIDELINE; RISK ASSESSMENT; TIME; TREATMENT OUTCOME; VERY ELDERLY;

ADVISORY COMMITTEES; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; COGNITION DISORDERS; CONSENSUS; DEMENTIA; DIETARY SUPPLEMENTS; FEMALE; FOLLOW-UP STUDIES; GERIATRIC ASSESSMENT; HUMANS; INTERNATIONAL COOPERATION; MALE; PRACTICE GUIDELINES AS TOPIC; RISK ASSESSMENT; TIME FACTORS; TREATMENT OUTCOME; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84916885277     PISSN: 09546820     EISSN: 13652796     Source Type: Journal    
DOI: 10.1111/joim.12279     Document Type: Review

References (76)

1. Holick MF. Vitamin D deficiency. N Engl J Med 2007; 357: 266-81.
2. Annweiler C, Souberbielle JC, Schott AM, de Decker L, Berrut G, Beauchet O. Vitamin D in the elderly: 5 points to remember. Geriatr Psychol Neuropsychiatr Vieil 2011; 9: 259-67.
3. McGrath J, Feron F, Eyles D, Mackay-Sim A. Vitamin D: the neglected neurosteroid? Trends Neurosci 2001; 24: 570-2.
4. Garcion E, Wion-Barbot N, Montero-Menei CN, Berger F, Wion D. New clues about vitamin D functions in the nervous system. Trends Endocrinol Metab 2002; 13: 100-5.
5. Kalueff AV, Tuohimaa P. Neurosteroid hormone vitamin D and its utility in clinical nutrition. Curr Opin Clin Nutr Metab Care 2007; 10: 12-9.
6. Buell JS, Dawson-Hughes B. Vitamin D and neurocognitive dysfunction: preventing 'D'ecline? Mol Aspects Med 2008; 29: 415-22.
7. Annweiler C, Schott AM, Berrut G et al. Vitamin D and ageing: neurological issues. Neuropsychobiology 2010; 62: 139-50.
8. Dickens AP, Lang IA, Langa KM, Kos K, Llewellyn DJ. Vitamin D, cognitive dysfunction and dementia in older adults. CNS Drug 2011; 25: 629-39.
9. Annweiler C, Allali G, Allain P et al. Vitamin D and cognitive performance in adults: a systematic review. Eur J Neurol 2009; 16: 1083-9.
10. Etgen T, Sander D, Bickel H, Sander K, Forstl H. Vitamin D deficiency, cognitive impairment and dementia: a systematic review and meta-analysis. Dement Geriatr Cogn Disord 2012; 33: 297-305.
11. Annweiler C, Llewellyn DJ, Beauchet O. Low serum vitamin D concentrations in Alzheimer's disease: a systematic review and meta-analysis. J Alzheimers Dis 2013; 33: 659-74.
12. Balion C, Griffith LE, Strifler L et al. Vitamin D, cognition, and dementia: a systematic review and meta-analysis. Neurology 2012; 79: 1397-405.
13. Annweiler C, Montero-Odasso M, Llewellyn DJ, Richard-Devantoy S, Duque G, Beauchet O. Meta-analysis of memory and executive dysfunctions in relation to vitamin D. J Alzheimers Dis 2013; 37: 147-71.
14. Holmøy T, Moen ST, Gundersen TA et al. 25-Hydroxyvitamin D in cerebrospinal fluid during relapse and remission of multiple sclerosis. Mult Scler 2009; 15: 1280-5.
15. Balabanova S, Richter HP, Antoniadis G et al. 25-Hydroxyvitamin D, 24, 25-dihydroxyvitamin D and 1, 25-dihydroxyvitamin D in human cerebrospinal fluid. Klin Wochenschr 1984; 62: 1086-90.
16. Brown J, Bianco JI, McGrath JJ, Eyles DW. 1, 25-Dihydroxyvitamin D-3 induces nerve growth factor, promotes neurite outgrowth and inhibits mitosis in embryonic rat hippocampal neurons. Neurosci Lett 2003; 343: 139-43.
17. Moore ME, Piazza A, McCartney Y, Lynch MA. Evidence that vitamin D3 reverses age-related inflammatory changes in the rat hippocampus. Biochem Soc Trans 2005; 33: 573-7.
18. Masoumi A, Goldenson B, Ghirmai S et al. 1Alpha, 25-dihydroxyvitamin D3 interacts with curcuminoids to stimulate amyloid-beta clearance by macrophages of Alzheimer's disease patients. J Alzheimers Dis 2009; 17: 703-17.
19. Ito S, Ohtsuki S, Nezu Y et al. 1α, 25-Dihydroxyvitamin D3 enhances cerebral clearance of human amyloid-β peptide(1-40) from mouse brain across the blood-brain barrier. Fluids Barriers CNS 2011; 8: 20.
20. Yu J, Gattoni-Celli M, Zhu H et al. Vitamin D3-enriched diet correlates with a decrease of amyloid plaques in the brain of AβPP Transgenic Mice. J Alzheimers Dis 2011; 25: 295-307.
21. Brewer LD, Thibault V, Chen KC et al. Vitamin D hormone confers neuroprotection in parallel with downregulation of L-type calcium channel expression in hippocampal neurons. J Neurosci 2001; 21: 98-108.
22. Dursun E, Gezen-Ak D, Yilmazer S. A novel perspective for Alzheimer's disease: vitamin D receptor suppression by amyloid-β induced alterations by vitamin D in cortical neurons. J Alzheimers Dis 2011; 23: 207-19.
23. Taniura H, Ito M, Sanada N et al. Chronic vitamin D3 treatment protects against neurotoxicity by glutamate in association with upregulation of vitamin D receptor mRNA expression in cultured rat cortical neurons. J Neurosci Res 2006; 83: 1179-89.
24. Ibi M, Sawada H, Nakanishi M et al. Protective effects of 1 alpha, 25-(OH)(2)D(3) against the neurotoxicity of glutamate and reactive oxygen species in mesencephalic culture. Neuropharmacology 2001; 40: 761-71.
25. Dawson VL, Dawson TM. Nitric oxide actions in neurochemistry. Neurochem Int 1996; 29: 97-110.
26. Garcion E, Nataf S, Berod A et al. 1, 25-Dihydroxyvitamin D3 inhibits the expression of inducible nitric oxide synthase in rat central nervous system during experimental allergic encephalomyelitis. Brain Res Mol Brain Res 1997; 45: 255-67.
27. Annweiler C, Beauchet O. Vitamin D-mentia: randomized clinical trials should be the next step. Neuroepidemiology 2011; 37: 249-58.
28. Dursun E, Gezen-Ak D, Yilmazer S. Beta amyloid suppresses the expression of the vitamin D receptor gene and induces the expression of the vitamin D catabolic enzyme gene in hippocampal neurons. Dement Geriatr Cogn Disord 2013; 36: 76-86.
29. Dursun E, Gezen-Ak D, Yilmazer S. A new mechanism for amyloid-β induction of iNOS: vitamin D-VDR pathway disruption. J Alzheimers Dis 2013; 36: 459-74.
30. Gezen-Ak D, Dursun E, Ertan T et al. Association between vitamin D receptor gene polymorphism and Alzheimer's disease. Tohoku J Exp Med 2007; 212: 275-82.
31. Gezen-Ak D, Dursun E, Bilgiç B et al. Vitamin D receptor gene haplotype is associated with late-onset Alzheimer's disease. Tohoku J Exp Med 2012; 228: 189-96.
32. Gezen-Ak D, Dursun E, Yilmazer S. Vitamin D inquiry in hippocampal neurons: consequences of vitamin D-VDR pathway disruption on calcium channel and the vitamin D requirement. Neurol Sci 2013; 34: 1453-8.
33. Beydoun MA, Ding EL, Beydoun HA, Tanaka T, Ferrucci L, Zonderman AB. Vitamin D receptor and megalin gene polymorphisms and their associations with longitudinal cognitive change in US adults. Am J Clin Nutr 2012; 95: 163-78.
34. Gezen-Ak D, Dursun E, Yilmazer S. The effects of vitamin D receptor silencing on the expression of LVSCC-A1C and LVSCC-A1D and the release of NGF in cortical neurons. PLoS ONE 2011; 6: e17553.
35. Keisala T, Minasyan A, Lou YR et al. Premature aging in vitamin D receptor mutant mice. J Steroid Biochem Mol Biol 2009; 115: 91-7.
36. Minasyan A, Keisala T, Lou YR, Kalueff AV, Tuohimaa P. Neophobia, sensory and cognitive functions, and hedonic responses in vitamin D receptor mutant mice. J Steroid Biochem Mol Biol 2007; 104: 274-80.
37. Burne TH, Johnston AN, McGrath JJ, Mackay-Sim A. Swimming behaviour and post-swimming activity in Vitamin D receptor knockout mice. Brain Res Bull 2006; 69: 74-8.
38. Burne TH, McGrath JJ, Eyles DW, Mackay-Sim A. Behavioural characterization of vitamin D receptor knockout mice. Behav Brain Res 2005; 157: 299-308.
39. Zou J, Minasyan A, Keisala T et al. Progressive hearing loss in mice with a mutated vitamin D receptor gene. Audiol Neurootol 2008; 13: 219-30.
40. Kalueff AV, Lou YR, Laaksi I, Tuohimaa P. Impaired motor performance in mice lacking neurosteroid vitamin D receptors. Brain Res Bull 2004; 64: 25-9.
41. Eyles D, Brown J, Mackay-Sim A, McGrath J, Feron F. Vitamin D3 and brain development. Neuroscience 2003; 118: 641-53.
42. Buell JS, Dawson-Hughes B, Scott TM et al. 25-Hydroxyvitamin D, dementia, and cerebrovascular pathology in elders receiving home services. Neurology 2010; 74: 18-26.
43. Annweiler C, Montero-Odasso M, Hachinski V, Seshadri S, Bartha R, Beauchet O. Vitamin D concentration and lateral cerebral ventricle volume in older adults. Mol Nutr Food Res 2013; 57: 267-76.
44. Wang Y, Chiang Y-H, Su TP et al. Vitamin D3 attenuates cortical infarction induced by middle cerebral arterial ligation in rats. Neuropharmacology 2000; 39: 873-80.
45. Brøndum-Jacobsen P, Nordestgaard BG, Schnohr P, Benn M. 25-hydroxyvitamin D and symptomatic ischemic stroke: an original study and meta-analysis. Ann Neurol 2013; 73: 38-47.
46. Annweiler C, Montero-Odasso M. Vascular burden as a substrate for higher-level gait disorders in older adults. A review of brain mapping literature. Panminerva Med 2012; 54: 189-204.
47. Slinin Y, Paudel ML, Taylor BC et al. 25-Hydroxyvitamin D levels and cognitive performance and decline in elderly men. Neurology 2010; 74: 33-41.
48. Llewellyn DJ, Lang IA, Langa KM et al. Vitamin D and risk of cognitive decline in elderly persons. Arch Intern Med 2010; 170: 1135-41.
49. Slinin Y, Paudel M, Taylor BC et al. Association between serum 25(OH) vitamin D and the risk of cognitive decline in older women. J Gerontol A Biol Sci Med Sci 2012; 67: 1092-8.
50. Afzal S, Bojesen SE, Nordestgaard BG. Reduced 25-hydroxyvitamin D and risk of Alzheimer's disease and vascular dementia. Alzheimers Dement 2014; 10: 296-302.
51. Annweiler C, Rolland Y, Schott AM, Blain H, Vellas B, Beauchet O. Serum vitamin D deficiency as a predictor of incident non-Alzheimer dementias: a 7-year longitudinal study. Dement Geriatr Cogn Disord 2011; 32: 273-8.
52. Annweiler C, Rolland Y, Schott AM et al. Higher vitamin D dietary intake is associated with lower risk of Alzheimer's disease: a 7-year follow-up. J Gerontol A Biol Sci Med Sci 2012; 67: 1205-11.
53. Annweiler C, Fantino B, Gautier J, Beaudenon M, Thiery S, Beauchet O. Cognitive effects of vitamin D supplementation in older outpatients visiting a memory clinic: a pre-post study. J Am Geriatr Soc 2012; 60: 793-5.
54. Stein MS, Scherer SC, Ladd KS, Harrison LC. A randomized controlled trial of high-dose vitamin D2 followed by intranasal insulin in Alzheimer's disease. J Alzheimers Dis 2011; 26: 477-84.
55. Prybelski R, Agrawal S, Krueger D, Engelke JA, Walbrun F, Binkley N. Rapid correction of low vitamin D status in nursing home residents. Osteoporos Int 2008; 19: 1621-8.
56. Annweiler C, Beauchet O. Vitamin D and cognition: recommendations for future trials. J Am Geriatr Soc 2013; 61: 1049-50.
57. Buell JS, Tucker KL. The value of physiologic vitamin D as a biomarker of dementia. Drugs Today (Barc) 2011; 47: 223-31.
58. Zhang J, Sokal I, Peskind ER et al. CSF multianalyte profile distinguishes Alzheimer and Parkinson diseases. Am J Clin Pathol 2008; 129: 526-9.
59. Abdi F, Quinn JF, Jankovic J et al. Detection of biomarkers with a multiplex quantitative proteomic platform in cerebrospinal fluid of patients with neurodegenerative disorders. J Alzheimers Dis 2006; 9: 293-348.
60. Chowdhury R, Kunutsor S, Vitezova A et al. Vitamin D and risk of cause specific death: systematic review and meta-analysis of observational cohort and randomised intervention studies. BMJ 2014; 348: g1903.
61. Zheng Y, Zhu J, Zhou M, Cui L, Yao W, Liu Y. Meta-analysis of long-term vitamin D supplementation on overall mortality. PLoS ONE 2013; 8: e82109.
62. Vieth R. Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety. Am J Clin Nutr 1999; 69: 842-56.
63. Chassagne P, Idrissi-Kassimy F, Rigal O. Comorbidity and dementia. Psychol Neuropsychiatr Vieil 2008; 6: 43-8.
64. Schlögl M, Holick MF. Vitamin D and neurocognitive function. Clin Interv Aging 2014; 9: 559-68.
65. Liu YT, Cai YF, Shi JP. Meta-analysis on the relationship between 25-hydroxyvitamin D level and hypertension. Zhonghua Yi Xue Za Zhi 2012; 92: 1268-71.
66. Abraham PS, Calès S, Redureau E et al. The vitamin 'D-bate': what vascular risk in geriatric inpatients? J Am Geriatr Soc 2011; 59: 1556-8.
67. Sanders KM, Stuart AL, Williamson EJ et al. Annual high-dose oral vitamin D and falls and fractures in older women: a randomized controlled trial. JAMA 2010; 303: 1815-22.
68. Grant WB. Trends in diet and Alzheimer's disease during the nutrition transition in Japan and developing countries. J Alzheimers Dis 2014; 38: 611-20.
69. Ralston SH. Bone mass through the lifespan. Womens Health Med 2006; 3: 145-8.
70. Féron F, Burne TH, Brown J et al. Developmental Vitamin D3 deficiency alters the adult rat brain. Brain Res Bull 2005; 65: 141-8.
71. O'Loan J, Eyles DW, Kesby J, Ko P, McGrath JJ, Burne TH. Vitamin D deficiency during various stages of pregnancy in the rat; its impact on development and behaviour in adult offspring. Psychoneuroendocrinology 2007; 32: 227-34.
72. Whitehouse AJ, Holt BJ, Serralha M, Holt PG, Kusel MM, Hart PH. Maternal serum vitamin D levels during pregnancy and offspring neurocognitive development. Pediatrics 2012; 129: 485-93.
73. Dean AJ, Bellgrove MA, Hall T et al. Effects of vitamin D supplementation on cognitive and emotional functioning in young adults-a randomised controlled trial. PLoS ONE 2011; 6: e25966.
74. Annweiler C, Beauchet O. Maternal vitamin D status in pregnancy and offspring brain development: the forgotten (but essential) needs of vitamin D era. Osteoporos Int 2014; 25: 1419-20.
75. Annweiler C, Herrmann FR, Fantino B, Brugg B, Beauchet O. Effectiveness of the combination of memantine plus vitamin D on cognition in patients with Alzheimer disease: a pre-post pilot study. Cogn Behav Neurol 2012; 25: 121-7.
76. Annweiler C, Brugg B, Peyrin JM, Bartha R, Beauchet O. Combination of memantine and vitamin D prevents axon degeneration induced by amyloid-beta and glutamate. Neurobiol Aging 2014; 35: 331-5.